| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.4M | +6.4% |
| Cost of Revenue | $6.9M | +6.9% |
| Gross Profit | $2.5M | +4.9% |
| R&D Expense | $1.7M | +30.8% |
| Operating Income | -$12.8M | -33.1% |
| Pre-tax Income | -$12.2M | -43.0% |
| Income Tax | $0 | — |
| Net Income | -$12.2M | -43.0% |
| EPS (Basic) | -$0.54 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.4M | -70.5% |
| Accounts Receivable | $1.0M | +48.6% |
| Inventory | $708K | +25.5% |
| Current Assets | $5.7M | -57.6% |
| Total Assets | $21.5M | -29.4% |
| Current Liabilities | $4.4M | +3.5% |
| Long-term Debt | $404K | +152.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.7M | -17.4% |
| Capital Expenditures | $277K | -59.4% |
| Investing Cash Flow | -$277K | +59.4% |
| Financing Cash Flow | -$225K | -101.4% |
| Free Cash Flow | -$8.0M | -10.2% |
| -35.0% |
| EPS (Diluted) | -$0.54 | -35.0% |
| Total Liabilities |
| $5.1M |
| -12.0% |
| Stockholders' Equity | $16.3M | -33.6% |